ES2057197T3 - Derivados de quinolina y procedimiento para su preparacion. - Google Patents

Derivados de quinolina y procedimiento para su preparacion.

Info

Publication number
ES2057197T3
ES2057197T3 ES90101210T ES90101210T ES2057197T3 ES 2057197 T3 ES2057197 T3 ES 2057197T3 ES 90101210 T ES90101210 T ES 90101210T ES 90101210 T ES90101210 T ES 90101210T ES 2057197 T3 ES2057197 T3 ES 2057197T3
Authority
ES
Spain
Prior art keywords
preparation
procedure
quinoline derivatives
useful
antibacterial agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90101210T
Other languages
English (en)
Spanish (es)
Inventor
Jun-Ichi Matsumoto
Teruyuki Miyamoto
Hiroshi Egawa
Shinichi Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2057197T3 publication Critical patent/ES2057197T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES90101210T 1985-10-29 1986-10-23 Derivados de quinolina y procedimiento para su preparacion. Expired - Lifetime ES2057197T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24225785 1985-10-29
JP28532385 1985-12-17
JP3262786 1986-02-17

Publications (1)

Publication Number Publication Date
ES2057197T3 true ES2057197T3 (es) 1994-10-16

Family

ID=27287785

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90101210T Expired - Lifetime ES2057197T3 (es) 1985-10-29 1986-10-23 Derivados de quinolina y procedimiento para su preparacion.
ES198686114748T Expired - Lifetime ES2029786T3 (es) 1985-10-29 1986-10-23 Procedimiento para preparar nuevos derivados de quinolina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES198686114748T Expired - Lifetime ES2029786T3 (es) 1985-10-29 1986-10-23 Procedimiento para preparar nuevos derivados de quinolina.

Country Status (26)

Country Link
US (1) US4795751A (en, 2012)
EP (2) EP0221463B1 (en, 2012)
JP (2) JPS62277362A (en, 2012)
KR (1) KR910006806B1 (en, 2012)
CN (1) CN1009930B (en, 2012)
AR (3) AR242031A1 (en, 2012)
AT (2) ATE66210T1 (en, 2012)
AU (1) AU594983B2 (en, 2012)
CA (1) CA1340402C (en, 2012)
DE (3) DE10075028I2 (en, 2012)
DK (2) DK170593B1 (en, 2012)
ES (2) ES2057197T3 (en, 2012)
FI (1) FI87457C (en, 2012)
GE (1) GEP19960467B (en, 2012)
GR (1) GR3002475T3 (en, 2012)
HU (1) HU200452B (en, 2012)
IL (1) IL80404A (en, 2012)
LU (2) LU88596I2 (en, 2012)
MY (1) MY100574A (en, 2012)
NL (2) NL970020I2 (en, 2012)
NO (1) NO170726C (en, 2012)
NZ (1) NZ218089A (en, 2012)
PH (1) PH22862A (en, 2012)
PT (1) PT83643B (en, 2012)
SU (2) SU1598873A3 (en, 2012)
YU (3) YU46414B (en, 2012)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JPH0674261B2 (ja) * 1988-06-21 1994-09-21 塩野義製薬株式会社 キノロンカルボン酸誘導体
JP2709604B2 (ja) * 1988-06-29 1998-02-04 大日本製薬株式会社 マイコプラズマ汚染の防止または除去
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
FR2655545B1 (fr) 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
FR2681863B1 (fr) * 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
TW222272B (en, 2012) * 1992-05-26 1994-04-11 Ss Seiyaku Kk
WO1993025545A1 (en) * 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
CN1038326C (zh) * 1993-07-20 1998-05-13 爱斯制药株式会社 5－氨基喹诺酮羧酸衍生物及其含有该衍生物作为活性成分的抗菌剂
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
DE1135132T1 (de) 1998-12-04 2002-08-22 Influx, Inc. Inhibitoren des multidrogentransportes
JP4694669B2 (ja) 1999-03-17 2011-06-08 第一三共株式会社 医薬組成物
CN1091103C (zh) * 1999-04-02 2002-09-18 中国科学院上海药物研究所 一类喹诺酮类化合物及它的制备和其用途
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
TWI289141B (en) * 2003-03-11 2007-11-01 Hoffmann La Roche F. Ag. Quinolinone derivatives and uses thereof
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
EP3641747B1 (en) 2017-06-22 2023-09-06 Cipla Limited Par-4 secretagogues for the treatment of cancer
CN112870196B (zh) * 2019-11-11 2022-02-18 山东畜牧兽医职业学院 一种治疗耐药性微生物菌的组合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS58174367A (ja) 1982-04-07 1983-10-13 Tanabe Seiyaku Co Ltd キノリン誘導体及びその製法
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS60169475A (ja) * 1984-02-14 1985-09-02 Dai Ichi Seiyaku Co Ltd キノリン誘導体
DE3574380D1 (en) * 1984-02-17 1989-12-28 Daiichi Seiyaku Co 1,8-naphthyridine derivatives
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
ZA852369B (en) 1984-04-26 1985-12-24 Abbott Lab Quinoline antibacterial compounds
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420798A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
JPS6110574A (ja) * 1984-06-25 1986-01-18 Hokuriku Seiyaku Co Ltd ６−フルオロ−１，４−ジヒドロ−４−オキソ−７−置換ピペラジニルキノリン−３−カルボン酸誘導体
IE58742B1 (en) 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPS6191183A (ja) * 1984-10-11 1986-05-09 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0181521A1 (en) * 1984-10-19 1986-05-21 Otsuka Pharmaceutical Co., Ltd. Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones
DE3576335D1 (de) * 1984-12-14 1990-04-12 Daiichi Seiyaku Co Chinolincarbonsaeure-derivate.
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
JPS6259263A (ja) * 1985-09-10 1987-03-14 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
GB8612137D0 (en) * 1986-05-19 1986-06-25 Fujisawa Pharmaceutical Co Quinolone compounds

Also Published As

Publication number Publication date
GR3002475T3 (en) 1992-12-30
HU200452B (en) 1990-06-28
GEP19960467B (en) 1996-05-27
NL300014I1 (nl) 2000-10-02
DE3650018T2 (de) 1995-01-05
AU6427786A (en) 1987-04-30
MY100574A (en) 1990-12-15
AR243520A1 (es) 1993-08-31
NO170726C (no) 1992-11-25
NZ218089A (en) 1989-03-29
NO170726B (no) 1992-08-17
ES2029786T3 (es) 1992-10-01
CA1340402C (en) 1999-02-23
DK25992D0 (da) 1992-02-28
NL300014I2 (nl) 2001-02-01
EP0375658B1 (en) 1994-08-03
DE3650018D1 (de) 1994-09-08
AR242031A1 (es) 1993-02-26
AU594983B2 (en) 1990-03-22
NO864247D0 (no) 1986-10-23
CN86107491A (zh) 1987-04-29
IL80404A0 (en) 1987-01-30
YU183586A (en) 1988-04-30
DK170774B1 (da) 1996-01-15
DE10075028I1 (de) 2000-12-14
HUT43839A (en) 1987-12-28
YU137291A (sh) 1994-01-20
YU46414B (sh) 1993-10-20
FI87457C (fi) 1993-01-11
LU88596I2 (fr) 1995-07-10
EP0221463B1 (en) 1991-08-14
JPH0541633B2 (en, 2012) 1993-06-24
FI87457B (fi) 1992-09-30
DE10075028I2 (de) 2004-01-29
SU1635898A3 (ru) 1991-03-15
EP0221463A3 (en) 1987-12-02
JPS62277362A (ja) 1987-12-02
PT83643A (en) 1986-11-01
ATE66210T1 (de) 1991-08-15
PH22862A (en) 1989-01-19
KR870004019A (ko) 1987-05-06
EP0221463A2 (en) 1987-05-13
LU90621I2 (fr) 2000-10-09
DK514586D0 (da) 1986-10-28
FI864299A0 (fi) 1986-10-23
NL970020I1 (nl) 1997-08-01
ATE109472T1 (de) 1994-08-15
DK514586A (da) 1987-04-30
JPH0714918B2 (ja) 1995-02-22
AR243178A1 (es) 1993-07-30
US4795751A (en) 1989-01-03
DK25992A (da) 1992-02-28
FI864299L (fi) 1987-04-30
NL970020I2 (nl) 1998-01-05
CN1009930B (zh) 1990-10-10
PT83643B (pt) 1988-10-14
NO864247L (no) 1987-04-30
IL80404A (en) 1990-06-10
YU137191A (sh) 1994-01-20
EP0375658A1 (en) 1990-06-27
DE3680859D1 (de) 1991-09-19
DK170593B1 (da) 1995-11-06
JPH0543551A (ja) 1993-02-23
KR910006806B1 (ko) 1991-09-02
SU1598873A3 (ru) 1990-10-07

Similar Documents

Publication Publication Date Title
ES2057197T3 (es) Derivados de quinolina y procedimiento para su preparacion.
AR000038A2 (es) Compuestos intermediarios de piridinosulfonamida sustituidos, y procedimientos para su obtencion.
ES464324A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina de actividad parasiticida.
ES2043617T3 (es) Un procedimiento para preparar derviados de benzamida.
MX173140B (es) Derivados aromaticos y heterociclicos de carboxamida, utiles como agentes antitumorales y procedimiento para su preparacion
JPS51115478A (en) Piperidine derivatives acid addidion salt and optical isomer
DE3687599D1 (de) Optisch aktive pyridobenzoxazinderivate.
ES480109A1 (es) Procedimkiento para la preparacion de derivados de imidazo- lidina.
ES2087097T3 (es) Derivados de acidos fenilcarboxilicos que contienen un heterociclo.
ES8507534A1 (es) Procedimiento para la preparacion de derivados benzopiranicos
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
AR241422A1 (es) Procedimiento para la preparacion de derivados de difenil(metil-etil-0 etenil) piperidinas.
IT7824708A0 (it) Procedimento di fabbricazione di derivato n-acilato di aminoacido.
ATE277017T1 (de) 1,2-disubstituierte 1,4-dihydro-4-oxochinolin- verbindungen
ES2102043T3 (es) Derivados de 22-en-25-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que los contienen, asi como su utilizacion en calidad de medicamentos.
FR2367743A1 (fr) Derives aryle conten
ATE43140T1 (de) Derivate von enzym-hemmender griseolsaeure und deren verwendung.
ES483152A1 (es) Procedimiento para preparar derivados de feniliminometil-pi-ridina
ES8104199A1 (es) Procedimiento de preparacion de nuevos derivados de benzoil-2 nitro-4 anilidas y sus sales
ES2057031T3 (es) Compuestos de nucleosido de 2'-metilidenpirimidina, su uso y metodo para su produccion.
ES392819A1 (es) Procedimiento para la preparacion de compuestos de amino-s-triazolilbencenosulfonamida.
ES2031457T3 (es) Derivados de 5-aminialquil-beta-carbolina, a su preparacion y a su utilizacion como medicamentos.
ES2017607T3 (es) Sales de amina de 2-alcoxi-2-oxidos del acido 1,4,2-oxazafosfolidin-4-acetico.
ES448907A1 (es) Un procedimiento para la preparacion de derivados de 1,2,3, 4-tetrahidroisoquinoleina.
ES484246A1 (es) Procedimiento de preparacion de nuevos derivados de ortoclo-robenzoil-2-cloro-4 glicilanilidas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 375658

Country of ref document: ES